Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.

@article{Rezaee2016IntraductalPM,
  title={Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.},
  author={Neda Rezaee and Carlotta Barbon and Ahmed Zaki and Jin He and Bulent Salman and Ralph H. Hruban and John L. Cameron and Joseph M. Herman and Nita Ahuja and Anne Marie Lennon and Matthew J Weiss and Laura D Wood and Christopher L. Wolfgang},
  journal={HPB : the official journal of the International Hepato Pancreato Biliary Association},
  year={2016},
  volume={18 3},
  pages={236-46}
}
BACKGROUND Non-invasive intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia and IPMN-associated invasive pancreatic ductal adenocarcinoma (PDAC) are frequently included under the term "malignancy". The goal of this study is to clarify the difference between these two entities. METHODS From 1996 to 2013, data of 616 patients who underwent pancreatic resection for an IPMN were reviewed. RESULTS The median overall survival for patients with IPMN with high-grade dysplasia… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…